High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/47.1.87PMID 11152436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia

  1998cited by this paper
• In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.

  1997cited by this paper
• Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

  1997cited by this paper
• Nomenclature for aerobic and facultative bacteria.

  1997cited by this paper
• Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

  1996cited by this paper
• Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.

  1995cited by this paper
• Nomenclature for aerobic and facultative bacteria.

  1993cited by this paper
• Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia

  1993cited by this paper
• In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures

  1992cited by this paper
• Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

  1992cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Analysis of Clinical Characteristics and Antimicrobial Resistance in 249 Isolates of Streptococcus mitis: a Single-Centre Study

  2025cites this paper
• The smiting of Streptococcus mitis and Streptococcus oralis: A novel antimicrobial proposition

  2025cites this paper
• Ceftriaxone-resistant viridans streptococci bacteraemia among patients treated at a large comprehensive cancer care centre: a retrospective eighteen-year study

  2024cites this paper
• Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021

  2023cites this paper
• Bacterial cell membranes and their role in daptomycin resistance: A review

  2022cites this paper
• Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility

  2022cites this paper
• Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration

  2021cites this paper
• Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model

  2020cites this paper
• Mechanistic Insights into the Differential Efficacy of Daptomycin plus β-Lactam Combinations against Daptomycin-Resistant Enterococcus faecium.

  2020cites this paper
• Streptococcus mitis/oralis Causing Blood Stream Infections in Pediatric Patients.

  2019cites this paper
• AMR - An R Package for Working with Antimicrobial Resistance Data

  2019cites this paper
• Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient.

  2019cites this paper
• Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model

  2019cites this paper
• Infections in cancer

  2018cites this paper
• Management of Infections in the Immunocompromised Host

  2018influential citation
• Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study

  2017cites this paper
• Tricuspid Valve Endocarditis Partly Due to a Penicillin Susceptible, Ceftriaxone-Resistant Streptococcus anginosus Isolate.

  2017cites this paper
• Whole-Genome Sequencing and Concordance Between Antimicrobial Susceptibility Genotypes and Phenotypes of Bacterial Isolates Associated with Bovine Respiratory Disease

  2017cites this paper
• Antibiotic resistance profiles of Pseudomonas aeruginosa isolated from various Greek aquatic environments.

  2016cites this paper
• Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland

  2016cites this paper
• The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

  2016cites this paper
• Multidrug resistant, extended spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from a dairy farm.

  2016cites this paper
• Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital

  2016cites this paper
• Supportive care in pediatric oncology: oncologic emergencies and management of fever and neutropenia.

  2015cites this paper
• Predictors and Outcomes of Viridans Group Streptococcal Infections in Pediatric Acute Myeloid Leukemia: From the Canadian Infections in AML Research Group

  2014cites this paper
• Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.

  2014cites this paper
• Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?

  2014cites this paper
• Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?

  2014cites this paper
• Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.

  2013cites this paper
• Addressing Antimicrobial Resistance in Dentistry

  2013cites this paper
• The comparative efficacy of 0.12% chlorhexidine and amoxicillin to reduce the incidence and magnitude of bacteremia during third molar extractions: a prospective, blind, randomized clinical trial.

  2013cites this paper
• Drug cost implications for antibiotic prophylaxis for dental procedures.

  2013cites this paper
• [Daptomycin in Gram-positive bacterial infections in oncohematological patients and transplant recipients].

  2012cites this paper
• Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli.

  2012cites this paper
• Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.

  2012cites this paper
• From phenotype to genotype: a Bayesian solution

  2011cites this paper
• Expert Systems in Clinical Microbiology

  2011cites this paper
• Clinical investigation of bacteremia in children with hemato-oncologic diseases.

  2011cites this paper
• Optimizing Antimicrobial Susceptibility Test Reporting

  2011cites this paper
• Serratia Infections: from Military Experiments to Current Practice

  2011cites this paper
• Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

  2010cites this paper
• The dental treatment of patients with joint replacements: a position paper from the American Academy of Oral Medicine.

  2010cites this paper
• Antibiotic Resistance of Non-Pneumococcal Streptococci and Its Clinical Impact

  2009influential citation
• Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.

  2008cites this paper
• Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

  2008cites this paper
• Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.

  2008cites this paper
• Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.

  2008cites this paper
• Infections with viridans group streptococci in children with cancer

  2007cites this paper
• In vitro susceptibility of viridans group streptococci isolated from blood in southwest Finland in 1993–2004

  2007cites this paper
• Empiric therapy for febrile neutropenia: what are the choices?

  2007cites this paper
• Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain.

  2007cites this paper
• A Guideline From the American Heart Association Rheumatic Prevention of Infective Endocarditis : Guidelines From the American Heart

  2007cites this paper
• Prevención de endocarditis infecciosa. Guías de la American Heart Association

  2007cites this paper
• An observational study on the empiric use of cefpirome in febrile neutropenia.

  2007cites this paper
• Prevention of Infective Endocarditis

  2007cites this paper
• Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardi

  2007cites this paper
• Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate

  2006cites this paper
• Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.

  2006cites this paper
• Pathogenesis of Oral Streptococci

  2006cites this paper
• Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients

  2006cites this paper
• Infectious Complications of Cancer Therapy

  2006cites this paper
• Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.

  2006cites this paper
• VIRIDANS GROUP STREPTOCOCCI SEPTICAEMIA AND ENDOCARDITIS

  2005influential citation
• Phenotypic detection of beta-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System.

  2005cites this paper
• Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.

  2004cites this paper
• Molecular Epidemiology of Serratia marcescens in Two Hospitals in Danzig, Poland, over a 5-Year Period

  2004cites this paper
• Will triclosan in toothpaste select for resistant oral streptococci?

  2003cites this paper
• Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment.

  2003cites this paper
• Gingivitis and toothbrushes: potential roles in viridans streptococcal bacteraemia.

  2003cites this paper
• Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia marcescens outbreaks.

  2003cites this paper
• Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.

  2003cites this paper
• [Update on the susceptibility of streptococci to antibiotics (enterococci and Streptococcus pneumoniae excluded)].

  2003cites this paper
• Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

  2003cites this paper
• Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000

  2002cites this paper
• Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period

  2002cites this paper
• Managing the child with fever and neutropenia in an era of increasing microbial resistance.

  2002cites this paper
• Infections caused by viridans streptococci in patients with neutropenia.

  2002cites this paper
• Apparent failure of endocarditis prophylaxis caused by penicillin-resistant Streptococcus mitis.

  2002cites this paper